Langerhans cell histiocytosis historical perspective: Difference between revisions
No edit summary |
|||
| Line 9: | Line 9: | ||
* Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term eosinophilic granuloma (Letterer–Siwe disease) to describe a similar clinical entity of the disease. | * Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term eosinophilic granuloma (Letterer–Siwe disease) to describe a similar clinical entity of the disease. | ||
* It was not until the year 1941 that Dr. Sidney Farber, a pathologist at Boston Children Hospital, unified the clinically similar conditions under the term Langerhans cell histocytosis (histiocytosis X). | * It was not until the year 1941 that Dr. Sidney Farber, a pathologist at Boston Children Hospital, unified the clinically similar conditions under the term Langerhans cell histocytosis (histiocytosis X). | ||
* Following the advances of electron microscopy, the term Birbeck granules was first used to describe the characteristic particles found in Langerhan cells in 1961. | |||
* The phagocytic nature of Langerhan cells was first described in 1973 by Dr Christian Nezelof .<ref name="pmid317149">{{cite journal| author=Nezelof C| title=Histiocytosis X: a histological and histogenetic study. | journal=Perspect Pediatr Pathol | year= 1979 | volume= 5 | issue= | pages= 153-78 | pmid=317149 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=317149 }} </ref> | |||
==References== | ==References== | ||
Revision as of 14:58, 3 February 2016
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis historical perspective |
|
Langerhans cell histiocytosis historical perspective in the news |
|
Blogs on Langerhans cell histiocytosis historical perspective |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The clinical presentation of Langerhans cell histiocytosis was first described by Dr. Alfred Hand Jr., an American pediatrician, in 1893.[1] The term Langerhans cell histocytosis was first used to describe the disease by Dr. Sidney Farber, a pathologist at Boston Children Hospital, in 1941.[1]
Historical Perspective
- The clinical presentation of Langerhans cell histiocytosis was first described by Alfred Hand Jr., an American pediatrician, in 1893.[1]
- The term Hand-Schüller-Christian disease was first used to describe the clinical entity following the work of Dr. Artur Schüller and Dr. Henry Christian.
- Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term eosinophilic granuloma (Letterer–Siwe disease) to describe a similar clinical entity of the disease.
- It was not until the year 1941 that Dr. Sidney Farber, a pathologist at Boston Children Hospital, unified the clinically similar conditions under the term Langerhans cell histocytosis (histiocytosis X).
- Following the advances of electron microscopy, the term Birbeck granules was first used to describe the characteristic particles found in Langerhan cells in 1961.
- The phagocytic nature of Langerhan cells was first described in 1973 by Dr Christian Nezelof .[2]
References
- ↑ 1.0 1.1 1.2 DiCaprio MR, Roberts TT (2014). "Diagnosis and Management of Langerhans Cell Histiocytosis". J Am Acad Orthop Surg. 22 (10): 643–652. doi:10.5435/JAAOS-22-10-643. PMID 25281259.
- ↑ Nezelof C (1979). "Histiocytosis X: a histological and histogenetic study". Perspect Pediatr Pathol. 5: 153–78. PMID 317149.